Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease
Objectives: (1) to determine the adherence and persistence rates of adalimumab therapy among Swedish patients with Crohn's disease (CD), and (2) to compare self-administration devices to predict the medication adherence and persistence. Methods: We conducted a retrospective analysis of the Swed...
Saved in:
Main Authors: | Yifei Liu (Author), Joakim Söderberg (Author), Jingdong Chao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difficult-to-treat-pediatric Crohn's disease: focus on adalimumab
by: Zeisler B, et al.
Published: (2015) -
Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn's disease
by: Liang Chen, et al.
Published: (2022) -
Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence
by: Celia Posada, et al.
Published: (2011) -
Langerhans Cell Histiocytosis Caused by Adalimumab for Crohn's Disease: A Case Report
by: Mariko Kochi, et al.
Published: (2023) -
Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn's Disease
by: Beatriz Orts, et al.
Published: (2022)